Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Adam Myszczyszyn"'
Autor:
Adam Myszczyszyn, Oliver Popp, Severine Kunz, Anje Sporbert, Simone Jung, Louis C. Penning, Annika Fendler, Philipp Mertins, Walter Birchmeier
Publikováno v:
PLoS ONE, Vol 19, Iss 3 (2024)
Externí odkaz:
https://doaj.org/article/45df5d4b3c334d8c8c244cadd07071d1
Autor:
Marit Keuper-Navis, Markus Walles, Birk Poller, Adam Myszczyszyn, Thomas K. van der Made, Joanne Donkers, Hossein Eslami Amirabadi, Martijn J. Wilmer, Saskia Aan, Bart Spee, Rosalinde Masereeuw, Evita van de Steeg
Publikováno v:
Pharmacological Research, Vol 195, Iss , Pp 106853- (2023)
Organ-on-chip (OoC) technology has led to in vitro models with many new possibilities compared to conventional in vitro and in vivo models. In this review, the potential of OoC models to improve the prediction of human oral bioavailability and intrin
Externí odkaz:
https://doaj.org/article/06d95e9d904945618f9e6018cbd79e94
Autor:
Annika Fendler, Daniel Bauer, Jonas Busch, Klaus Jung, Annika Wulf-Goldenberg, Severine Kunz, Kun Song, Adam Myszczyszyn, Sefer Elezkurtaj, Bettina Erguen, Simone Jung, Wei Chen, Walter Birchmeier
Publikováno v:
Nature Communications, Vol 11, Iss 1, Pp 1-16 (2020)
Cancer stem cells are thought to be largely resistant to treatment and can be responsible for tumour recurrence. Here, using renal cancer organoids, self-renewing sphere cultures and PDX from patients, the authors show that the proliferation of stem
Externí odkaz:
https://doaj.org/article/e20e23a96a924161a7b8a3b6741f03e9
Autor:
Adam Myszczyszyn, Oliver Popp, Severine Kunz, Anje Sporbert, Simone Jung, Louis C. Penning, Annika Fendler, Philipp Mertins, Walter Birchmeier
Previously, we found that Wnt and Notch signaling govern stem cells of clear cell kidney cancer (ccRCC) in patients. To mimic stem cell responses in the normal kidney in vitro in a marker-unbiased fashion, we have established organoids from total sin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cb592850a0ab2f4e1a761ead54c2f2ce
https://doi.org/10.1101/2023.02.28.530413
https://doi.org/10.1101/2023.02.28.530413
Autor:
Lukasz Szymanski, Anna M. Czarnecka, Cezary Szczylik, Adam Myszczyszyn, Klaudia Brodaczewska, Monika Lipiec, Sławomir Lewicki, Damian Matak, Irena Koch, Robert Zdanowski
Publikováno v:
BMC Cancer
Background CD105 was postulated as a renal cell carcinoma (RCC) stem cell marker, and CD133 as a putative RCC progenitor. Hypoxia, a natural microenvironment that prevails in tumors, was also incorporated into the study, especially in terms of the pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2da925bc6630ceb9ff1374286f91e2f
https://pubmed.ncbi.nlm.nih.gov/28056882
https://pubmed.ncbi.nlm.nih.gov/28056882
Autor:
Lukasz Szymanski, Fei Lian, Adam Myszczyszyn, Damian Matak, Wojciech Kukwa, Anna Kornakiewicz, Cezary Szczylik, Claudine Kieda, Anna M. Czarnecka, Ewa Bartnik
Publikováno v:
Stem Cell Reviews and Reports
Stem Cell Reviews and Reports, Humana Press, 2015, 11 (6), pp.919-943. ⟨10.1007/s12015-015-9611-y⟩
Stem Cell Reviews
Stem Cell Reviews and Reports, Humana Press, 2015, 11 (6), pp.919-943. ⟨10.1007/s12015-015-9611-y⟩
Stem Cell Reviews
International audience; The cancer stem cell (CSC) model has recently been approached also in renal cell carcinoma (RCC). A few populations of putative renal tumor-initiating cells (TICs) were identified, but they are indifferently understood ; howev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e084793309acb64e4a3c68ddae4756b9
https://hal.archives-ouvertes.fr/hal-02072287
https://hal.archives-ouvertes.fr/hal-02072287